• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异动症大鼠中多巴胺受体调节的超直接通路γ活动的时间特征

Temporal Features of Gamma Activity of Hyper-direct Pathway Regulated by Dopamine Receptors in the Dyskinetic Rat.

作者信息

Wang Pengfei, Dai Weina, Li Hongmin, Li Weijie, Wang Yang, Liu Yichang, Wang Le, Ye Fanglei, Xu Yuming

机构信息

Department of Otology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450015, China.

School of Basic Medical Science, North Henan Medical University, Xinxiang, 453003, China.

出版信息

Neurosci Bull. 2025 Aug 25. doi: 10.1007/s12264-025-01470-9.

DOI:10.1007/s12264-025-01470-9
PMID:40853582
Abstract

Cortico-thalamic projections (the hyper-direct pathway) are implicated in levodopa-induced dyskinesia (LID), a challenging complication in the advanced stages of Parkinson's disease (PD). Excessive beta and gamma activity in PD and LID has frequently been reported in recent cross-sectional studies. We aimed to investigate the temporal features of beta and gamma activity in the hyper-direct pathway during the development of PD and LID in rats, as well as the regulatory role of the dopamine receptors DI (D1Rs) and DIII (D3Rs) in these disorders. We recorded motor behavior and electrophysiological data during the development of PD and LID, and after interventions with D1R and D3R antagonists and agonists. We demonstrated exaggerated beta-band activity in the PD state and excessive gamma-band activity during on-state dyskinesia. Subsequently, process-dependent increased beta activity correlated with bradykinesia during PD modeling, while process-dependent increased gamma activity correlated with dyskinesia under the cumulative effects of levodopa during on-state dyskinesia. Finally, both D1Rs and D3Rs were found to be involved in regulating dyskinesia and gamma activity. Dynamic oscillations are closely associated with motor behavior, and mapping dynamic oscillations may be associated with optimizing deep brain stimulation parameters and developing personalized neurotherapeutic targeting. Moreover, D1Rs and D3Rs may ameliorate dyskinesia by mediating gamma oscillations.

摘要

皮质-丘脑投射(超直接通路)与左旋多巴诱导的异动症(LID)有关,LID是帕金森病(PD)晚期具有挑战性的并发症。近期的横断面研究经常报道PD和LID中存在过度的β和γ活动。我们旨在研究大鼠PD和LID发展过程中超直接通路中β和γ活动的时间特征,以及多巴胺受体D1(D1Rs)和D3(D3Rs)在这些疾病中的调节作用。我们记录了PD和LID发展过程中以及用D1R和D3R拮抗剂和激动剂干预后的运动行为和电生理数据。我们证明了在PD状态下β波段活动增强,在异动症开启状态下γ波段活动过度。随后,在PD建模过程中,过程依赖性增加的β活动与运动迟缓相关,而在异动症开启状态下,在左旋多巴的累积作用下,过程依赖性增加的γ活动与异动症相关。最后,发现D1Rs和D3Rs均参与调节异动症和γ活动。动态振荡与运动行为密切相关,绘制动态振荡图可能与优化深部脑刺激参数和开发个性化神经治疗靶点有关。此外,D1Rs和D3Rs可能通过介导γ振荡来改善异动症。

相似文献

1
Temporal Features of Gamma Activity of Hyper-direct Pathway Regulated by Dopamine Receptors in the Dyskinetic Rat.异动症大鼠中多巴胺受体调节的超直接通路γ活动的时间特征
Neurosci Bull. 2025 Aug 25. doi: 10.1007/s12264-025-01470-9.
2
Eltoprazine modulated gamma oscillations on ameliorating L-dopa-induced dyskinesia in rats.依替唑仑通过调节γ 振荡改善左旋多巴诱导的大鼠异动症。
CNS Neurosci Ther. 2023 Oct;29(10):2998-3013. doi: 10.1111/cns.14241. Epub 2023 Apr 30.
3
Modulation of Cerebellar Oscillations with Subthalamic Stimulation in Patients with Parkinson's Disease.小脑刺激对帕金森病患者的调节。
J Parkinsons Dis. 2024;14(7):1417-1426. doi: 10.3233/JPD-240065.
4
Functional motor network abnormalities associated with levodopa-induced dyskinesia in Parkinson's disease: A systematic review.与帕金森病左旋多巴诱导运动障碍相关的功能性运动网络异常:系统综述。
Neuroimage Clin. 2024;44:103705. doi: 10.1016/j.nicl.2024.103705. Epub 2024 Nov 14.
5
Pain Fluctuations in Parkinson's Disease and Their Association with Motor and Non-Motor Fluctuations.帕金森病的疼痛波动及其与运动和非运动波动的关系。
J Parkinsons Dis. 2024;14(7):1451-1468. doi: 10.3233/JPD-240026.
6
Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.帕金森病患者外部节拍手指敲击的运动前皮质β同步和网络神经调节。
Neurobiol Dis. 2024 Jul;197:106529. doi: 10.1016/j.nbd.2024.106529. Epub 2024 May 11.
7
AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia.AMPK 介导的自噬通路激活促进 ΔFosB 降解,改善左旋多巴诱导的异动症。
Cell Signal. 2024 Jun;118:111125. doi: 10.1016/j.cellsig.2024.111125. Epub 2024 Mar 1.
8
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.用于抗精神病药物所致迟发性运动障碍的非抗精神病类儿茶酚胺能药物。
Cochrane Database Syst Rev. 2018 Jan 18;1(1):CD000458. doi: 10.1002/14651858.CD000458.pub3.
9
Ropinirole for levodopa-induced complications in Parkinson's disease.罗匹尼罗用于治疗帕金森病中左旋多巴引起的并发症。
Cochrane Database Syst Rev. 2001(1):CD001516. doi: 10.1002/14651858.CD001516.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

本文引用的文献

1
Histaminergic Innervation of the Ventral Anterior Thalamic Nucleus Alleviates Motor Deficits in a 6-OHDA-Induced Rat Model of Parkinson's Disease.丘脑腹前核的组胺能神经支配减轻6-羟基多巴胺诱导的帕金森病大鼠模型中的运动缺陷。
Neurosci Bull. 2025 Apr;41(4):551-568. doi: 10.1007/s12264-024-01320-0. Epub 2024 Dec 2.
2
Eltoprazine modulated gamma oscillations on ameliorating L-dopa-induced dyskinesia in rats.依替唑仑通过调节γ 振荡改善左旋多巴诱导的大鼠异动症。
CNS Neurosci Ther. 2023 Oct;29(10):2998-3013. doi: 10.1111/cns.14241. Epub 2023 Apr 30.
3
Long-Term Recording of Subthalamic Aperiodic Activities and Beta Bursts in Parkinson's Disease.
帕金森病中丘脑底核非周期性活动和β波爆发的长期记录
Mov Disord. 2023 Feb;38(2):232-243. doi: 10.1002/mds.29276. Epub 2022 Nov 24.
4
Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia.D1 和 D2 受体激动剂对左旋多巴诱导的运动障碍啮齿动物模型皮质基底节振荡的独特影响。
Neurotherapeutics. 2023 Jan;20(1):304-324. doi: 10.1007/s13311-022-01309-5. Epub 2022 Nov 7.
5
Abnormal neural oscillations during gait and dual-task in Parkinson's disease.帕金森病患者步态和双任务过程中的异常神经振荡。
Front Syst Neurosci. 2022 Sep 15;16:995375. doi: 10.3389/fnsys.2022.995375. eCollection 2022.
6
Pharmacological targeting of G protein-coupled receptor heteromers.药物靶向作用于 G 蛋白偶联受体异源二聚体。
Pharmacol Res. 2022 Nov;185:106476. doi: 10.1016/j.phrs.2022.106476. Epub 2022 Sep 28.
7
Altered functional connectivity of cerebellar dentate nucleus in peak-dose dyskinesia in Parkinson's disease.帕金森病峰值剂量异动症中小脑齿状核功能连接的改变
Front Aging Neurosci. 2022 Aug 2;14:943179. doi: 10.3389/fnagi.2022.943179. eCollection 2022.
8
Parkinson's Disease: A Multisystem Disorder.帕金森病:一种多系统紊乱。
Neurosci Bull. 2023 Jan;39(1):113-124. doi: 10.1007/s12264-022-00934-6. Epub 2022 Aug 22.
9
Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence.帕金森病中左旋多巴诱导的异动症的分子机制和治疗策略:基于临床前和临床证据的视角
Front Pharmacol. 2022 Apr 7;13:805388. doi: 10.3389/fphar.2022.805388. eCollection 2022.
10
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson's Disease.帕金森病中 D3 受体的神经生物学和药理学观点。
Biomolecules. 2022 Feb 1;12(2):243. doi: 10.3390/biom12020243.